Cyfuse Biomedical KK
TSE:4892
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cyfuse Biomedical KK
TSE:4892
|
JP |
|
Magna International Inc
TSX:MG
|
CA |
|
Altus Group Ltd
TSX:AIF
|
CA |
|
AKB Primor'ye PAO
MOEX:PRMB
|
RU |
|
G
|
GIB Capital Group Inc
OTC:GIBX
|
US |
|
S
|
Srinanaporn Marketing PCL
SET:SNNP
|
TH |
|
Chevron Corp
NYSE:CVX
|
US |
|
M
|
Mr Blue Corp
KOSDAQ:207760
|
KR |
|
N
|
Nippon Express Holdings Inc
TSE:9147
|
JP |
|
Oriental Rail Infrastructure Ltd
BSE:531859
|
IN |
|
Star Diamond Corp
TSX:DIAM
|
CA |
Shareholder Yield
Current shareholder yield for Cyfuse Biomedical KK is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Cyfuse Biomedical KK
| Average Annual Return | -36.71% |
| Standard Deviation of Annual Returns | 10.44% |
| Max Drawdown | -80% |
| Market Capitalization | 5.8B JPY |
| Shares Outstanding | 9 970 000 |
| Percentage of Shares Shorted |
N/A
|
